Executive Vice President, Head of North America · RHYTHM PHARMACEUTICALS, INC. (RYTM)

Jennifer Chien

A named executive officer of RHYTHM PHARMACEUTICALS in every fiscal year CompBrief holds from FY2020 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$1,086,675

Salary $430,000Stock awards $93,500

FY2021: $2,081,452

4th of 5 named executive officers at Rhythm Pharmaceuticals by FY2022 total.

5 named officers on file for RHYTHM PHARMACEUTICALS, FY2022

Jennifer Chien’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 5 equity grants, each cited to its filing
  • RYTM’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how RHYTHM PHARMACEUTICALS’s whole pay program stands against its peers

  • RHYTHM PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RYTM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2023 (DEF 14A).

Free

Get Jennifer Chien’s full pay file as a PDF — free

More than this page: up to 10 years of Jennifer’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Jennifer Chien compensation by year

RHYTHM PHARMACEUTICALS Summary Compensation Table · all 3 fiscal years held
In US dollars, as RHYTHM PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022
Salary$45,577$395,000$430,000
Bonus$100,000$0$0
Stock awards$100,000$552,376$93,500
Option awards$1,517,540$931,613$348,975
Non-equity incentive$49,375$190,864$202,000
Pension and deferred compensation$0$0$0
All other$7,125$11,600$12,200
Total$1,819,617$2,081,452$1,086,675

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RHYTHM PHARMACEUTICALS, INC. DEF 14A filed April 27, 2023, accession 0001104659-23-051469, and prior-year filings. Open the filing on EDGAR.

How this page was built: the RHYTHM PHARMACEUTICALS, INC. filed document, accession 0001104659-23-051469. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2023.

$1.8M
$2.1M
$1.1M
FY20
FY21
FY22
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
PSU14,996$436,684—
RSU13,760$400,691—
RSU11,248$327,542—
RSU6,093$177,428—
Option50,000—$24.29
Option27,422—$30.66
Option67,031—$6.80

Per the Outstanding Equity Awards at Fiscal Year-End table in RHYTHM PHARMACEUTICALS, INC.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

RHYTHM PHARMACEUTICALS’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
David MeekerChief Executive Officer$3,325,758
Hunter SmithChief Financial Officer$1,215,125
Yann MazabraudExecutive Vice President, Head of International$1,189,905
Jennifer Chien · this pageExecutive Vice President, Head of North America$1,086,675
Joseph ShulmanChief Technical Officer$950,113

The full RHYTHM PHARMACEUTICALS compensation record

free company brief

This page is one person within RHYTHM PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the RHYTHM PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are RHYTHM PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jennifer Chien's compensation dossier · One-time report. No refunds.